Numazawa M, Mutsumi A, Ogata M, Osawa Y
Tohoku College of Pharmacy, Sendai, Japan.
Steroids. 1987 Apr-May;49(4-5):247-57. doi: 10.1016/0039-128x(87)90002-x.
3 beta,16 alpha,19-Trihydroxy-5-androsten-17-one and 16 alpha,17-dihydroxy-4-androstene-3,17-dione were synthesized from the 5 alpha-bromo-6 beta,19-epoxy-17-ketone derivative 1, using the bromination at C-16 alpha of the 17-ketone 1 and the controlled alkaline hydrolysis of the 16 alpha-bromo-17-ketones 2 and 11 as key reactions. Zinc dust reductive cleavage of the 6 beta,19-epoxy-16 alpha-hydroxy-17-ketones 4 and 12, produced by controlled hydrolysis, gave the corresponding 19-alcohol derivatives 6 and 14, which were rearranged to the 17 beta-hydroxy-16-ketones 7 and 15 when treated with sodium hydroxide. The 3 beta,16 alpha,17 beta,19-tetrol 8 was obtained from the 16 alpha-ketol 6 by reaction with sodium borohydride.
以5α-溴-6β,19-环氧-17-酮衍生物1为原料,通过17-酮1的C-16α溴化反应以及16α-溴-17-酮2和11的可控碱性水解反应,合成了3β,16α,19-三羟基-5-雄甾烯-17-酮和16α,17-二羟基-4-雄甾烯-3,17-二酮。可控水解产生的6β,19-环氧-16α-羟基-17-酮4和12经锌粉还原裂解,得到相应的19-醇衍生物6和14,用氢氧化钠处理时,它们重排为17β-羟基-16-酮7和15。3β,16α,17β,19-四醇8是由16α-酮醇6与硼氢化钠反应制得的。